FDA Enforcement Class II Ongoing

ARIES GBS Assay , REF 50-10021, UDI # 00840487100165

Recall: Z-2285-2019 · Reported August 21, 2019

Enforcement

Recall Number
Z-2285-2019
Event ID
83470
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Luminex Corporation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
August 21, 2019
Initiation Date
February 20, 2019
Classification Date
August 15, 2019
Address
12212 Technology Blvd, N/A, Austin, TX, 78727-6101, United States

Description

ARIES GBS Assay , REF 50-10021, UDI # 00840487100165

Reason

Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and decreased sensitivity or stability of the assay.

Code Info

Lot numbers & discontinue use by dates for part number 50-10021: AA7546 - 3/9/2019 AA7629 - 4/10/2019

Distribution

US: AK, AL, AZ,CA,CO,FL,GA,IL,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,NE,NJ,NM,NY,OH,ON,OR,PA,TN,TX,UT,VA,VT,WA,WI, OUS: Belgium, Canada, Thailand, Germany, Singapore, United Kingdom

Quantity

N/A